Apotex received tentative approval in April 2026, but Novo Nordisk's patents prevent it from launching until at least December 2031
The main ways theyre doing this are through what insurance companies call utilization management, which means looking at each persons eligibility on a case-by-case basis or by requiring that they try other therapies such as lifestyle management or older weight loss medications before they qualify for GLP-1 drugs
As more manufacturers bring generics to market, this daily GLP-1 medication may become a more practical option for people managing type 2 diabetes or exploring off-label weight loss support
Oto-Rhino-Laryngology 270, 13291334
The ELITE trial (N=643) divided postmenopausal women into early (less than 6 years since menopause) and late (more than 10 years since menopause) groups
When the medication reaches higher peak concentrations more quickly, some people experience a more pronounced sense of tiredness or lightheadedness